Weicheng Pharmaceuticals

Suzhou, China · Founded 2025 · Privately Held (backing)

Developer of a proprietary extrahepatic drug delivery platform designed to advance targeted small nucleic acid therapies beyond hepatic tissues. Weicheng Pharmaceuticals is based in Suzhou, China and was founded in 2025. It has raised $64 million.

Last price · $/share
—
Implied valuation
—
Total raised
$64.0M
Last round
—
Valuation — not yet established

No valuation for Weicheng Pharmaceuticals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($64.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.

Weicheng Pharmaceuticals funding history

No rounds on record

No funding rounds for Weicheng Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Weicheng Pharmaceuticals's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Weicheng Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Weicheng Pharmaceuticals

How much has Weicheng Pharmaceuticals raised?
Weicheng Pharmaceuticals has raised $64.0M in total funding across its recorded rounds.